Running a hospital isn’t easy-but HCA Healthcare’s scale gives it advantages that help it grow like few healthcare systems can, Nicholas Jasinski writes in this week’s edition of Barron’s. With the stock underperforming this year on weight-loss drug fears, shares now look like a buy, the author says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare price target lowered to $290 from $310 at Argus
- Early notable gainers among liquid option names on November 17th
- HCA Healthcare price target lowered to $265 from $313 at JPMorgan
- Third Point buys T-Mobile, boosts Microsoft in Q3
- HCA Healthcare provides five-year targets ahead of investor day
